HK$ 8.26
Key Takeaways
Risk factor
Resilient to price shocks
Profitability factor
Strong margins and returns
About
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare disease medicines. It also provides...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITDA, tradin
Target Price
The average target price of 0512.HK is 12 and suggests 43% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
